shortagewatch

Home / Dermatologicals / Budesonide

ATC D07AC09 · Corticosteroids, Potent (Group Iii)

Budesonide shortage

As of 2 Nov 2026, Budesonide has a reported shortage in 1 of the 16 countries we track (Japan), covering 2 products from 1 company.

Countries1/16
Products2packs or presentations
Companies10 listed
Short since8 Sep 202514 months ago
Earliest returnnot givencompany estimate
Main reasonActive ingredient shortage
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapan2 products shortNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Japan
2026ブデソニド吸入液0.25mg「武田テバ」ブデソニド吸入液0.25mg「武田テバ」ブデソニド吸入液0.5mg「武田テバ」ブデソニド吸入液0.5mg「武田テバ」today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
T S2

Compared with similar medicines

ATC group D07AC · Corticosteroids, Potent (Group Iii)
Betamethasone4/16Mometasone3/16Prednicarbate2/16Amcinonide1/16Budesonide1/16Fluocinolone Acetonide1/16Fluocinonide1/16

Affected products

CountryProductCompanySinceExpected backReason
ブデソニド吸入液0.25mg「武田テバ」 limitedT’sファーマ8 Sep 2025not givenActive ingredient shortage
Raw material (active ingredient) supply problem
ブデソニド吸入液0.5mg「武田テバ」 limitedT’sファーマ8 Sep 2025not givenActive ingredient shortage
Raw material (active ingredient) supply problem

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.